InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Sunday, 12/11/2022 11:17:13 AM

Sunday, December 11, 2022 11:17:13 AM

Post# of 461425
My view is that it did not, and does not, matter what the data or Missling or McFarlane said. AF and similar shorter types planned to attack, criticize and obfuscate to make some short term monetary gains!
Honest observers acknowledge that the data is very positive in regard to efficacy and safety...and detailed analysis will reveal it is even better than the summary data.
Five things can be expected
1. More granular analysis of the data.
2. Partnerships.
3. Expedited approvals as an early treatment.
4. Larger longer term preventive studies.
5. Combination therapy trials.
Australia, U.K. and European agencies can be expected to act first...UNLESS Alzheimer care-giver groups in the U.S. can mount enough pressure for some form of expedited approval. This is not a partisan issue. Alzheimers patients cannot speak for themselves. Their care-givers must stand up and speak up for their loved ones! It has happened before!

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News